Literature DB >> 28366028

Mutational Profile of Homozygous β-Thalassemia in Rio de Janeiro, Brazil.

Gisele C S Carrocini1, Larissa P R Venancio2, Viviani L R Pessoa3, Clarisse L C Lobo3, Claudia R Bonini-Domingos1.   

Abstract

β-Thalassemia (β-thal) is a hemolytic anemia that is caused by point mutations in most cases. The Brazilian population is highly heterogeneous and knowledge of the mutations that make up the genotypic profile of individuals can contribute information about the formation of the population and clinical condition of patients. In this study, we evaluated the mutations present in homozygous β-thal patients from Rio de Janeiro, Brazil. We analyzed 24 samples of peripheral blood of patients with homozygous β-thal. To identify the mutations, we carried out allele-specific-polymerase chain reaction (AS-PCR) and DNA sequencing. We found 11 different mutations on the β-globin gene. Among the most frequent mutations observed were HBB: c.92 + 6T>C, followed by HBB: c.93-21G>A, HBB: c.118C>T and HBB: c.92 + 1G>A. We also identified the rare mutation HBB: c.75T>A that was reported in an individual carrying Hb S (HBB: c.20A>T)/β-thal (HBB: c.75T>A) but not in Brazilian thalassemic patients, thus, this is the first report of this mutation in Brazilian β-thal patients. For its multiethnic character, Brazil has different mutations that cause β-thal and that are distributed with different frequencies according to the regions of the country. Our findings contribute to the description of the mutational profile of Brazilian thalassemic patients, showing wide heterogeneity and genetic variability.

Entities:  

Keywords:  hemoglobin (Hb); hemolytic anemia; molecular genetics; mutations; β-Thalassemia (β-thal)

Mesh:

Substances:

Year:  2017        PMID: 28366028     DOI: 10.1080/03630269.2017.1289958

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  2 in total

1.  Incidence of variant hemoglobins in newborns attended by a public health laboratory.

Authors:  Flávia Mylla de Sousa Reis; Renata Rodrigues de Oliveira Castelo Branco; Amanda Mota Conceição; Letícia Paula Benvindo Trajano; José Felipe Pinheiro do Nascimento Vieira; Pablo Ricardo Barbosa Ferreira; Éverton José Ferreira de Araújo
Journal:  Einstein (Sao Paulo)       Date:  2018-06-07

2.  Use of an automated pyrosequencing technique for confirmation of sickle cell disease.

Authors:  Camila Cruz de Martino; Cecilia Salete Alencar; Paula Loureiro; Anna Barbara de Freitas Carneiro-Proietti; Claudia de Alvarenga Máximo; Rosimere Afonso Mota; Daniela Oliveira Werneck Rodrigues; Nelson Gaburo Junior; Shannon Kelly; Ester Cerdeira Sabino
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.